Target colorectal screening based on life expectancyAnalysis shows lag-time for benefit exceeds 10 years Chemoradiotherapy superior in muscle-invasive bladder cancerRadiation alone is inferior, ‘remarkable’ study shows Here’s to self-experimentation Doctors down an antioxidant drink aimed at curbing radiation damage Too many colonoscopies? Followup intervals are too short, study suggests Xalkori for non-small-cell lung cancer New personalized therapy is for managing a specific type of non-small-cell lung cancer. Bacterium linked with colon cancer Finding could have implications for diagnosis and treatment Endometrial cancer needs a rethink Consortium aims for global impact in improving tumour classification Bladder cancer risk seen with pioglitazone Drug used to treat type 2 diabetes may carry a small risk of bladder cancer. Clinical Feature: Prostate cancer The pharmacist's role in prevention and management. New study examines cancer risk with ARBs Previous experimental work had raised theoretical concerns about the risk of cancer, since ARBs play a role in regulating angiogenesis, cell proliferation, and tumour progression. First Previous 42 43 44 45 46 Next Last